Insights

Strong Funding Backing Phil Inc. has secured significant financial support including a recent $60 million growth debt financing from K2 HealthVentures and a $60 million Series D funding led by Warburg Pincus, indicating robust growth potential and investment confidence which can open opportunities for strategic partnerships or expanding product offerings.

Expanding Partner Network The company's recent collaborations with major pharmaceutical companies like RedHill Biopharma and Teva Pharmaceuticals showcase their increasing adoption in the life sciences sector, presenting opportunities to engage additional pharmaceutical brands seeking innovative drug access solutions.

Market Adoption of Platforms Phil's platform has demonstrated strong market traction highlighted by the launch of key medications like Bonjesta and partnerships that enable drug prescriptions via its digital hub, suggesting high demand for integrated patient access solutions within pharmaceutical commercialization.

Technology-Driven Solution Employing advanced technology stacks such as MongoDB, Datadog, and Google Analytics, Phil positions itself as a digital leader in patient access and provider engagement platforms, ideal for technology-forward pharmaceutical companies aiming to modernize their commercialization strategies.

Growth in Revenue With annual revenues estimated between $250 million and $500 million and a growing client base, Phil offers substantial opportunities for sales expansion by targeting mid to large pharmaceutical firms seeking innovative access and adherence solutions.

Phil, Inc. Tech Stack

Phil, Inc. uses 8 technology products and services including Jenkins, MongoDB, Microsoft Intune, and more. Explore Phil, Inc.'s tech stack below.

  • Jenkins
    Continuous Integration
  • MongoDB
    Database
  • Microsoft Intune
    Enterprise Mobility Management
  • UPS
    Logistics
  • Cisco Meraki
    Network Hardware
  • Datadog
    Real User Monitoring
  • X-XSS-Protection
    Security
  • Google Analytics
    Web Analytics

Media & News

Phil, Inc.'s Email Address Formats

Phil, Inc. uses at least 1 format(s):
Phil, Inc. Email FormatsExamplePercentage
First@phil.usJohn@phil.us
53%
First.Last@phil.usJohn.Doe@phil.us
37%
FirstL@phil.usJohnD@phil.us
6%
FLast@phil.usJDoe@phil.us
4%

Frequently Asked Questions

What is Phil, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Phil, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Phil, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Phil, Inc.'s official website is phil.us and has social profiles on LinkedInCrunchbase.

What is Phil, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Phil, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Phil, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Phil, Inc. has approximately 283 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Cco: M. B.Chief Financial Officer: S. B.Vp Of Finance: P. W.. Explore Phil, Inc.'s employee directory with LeadIQ.

What industry does Phil, Inc. belong to?

Minus sign iconPlus sign icon
Phil, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Phil, Inc. use?

Minus sign iconPlus sign icon
Phil, Inc.'s tech stack includes JenkinsMongoDBMicrosoft IntuneUPSCisco MerakiDatadogX-XSS-ProtectionGoogle Analytics.

What is Phil, Inc.'s email format?

Minus sign iconPlus sign icon
Phil, Inc.'s email format typically follows the pattern of First@phil.us. Find more Phil, Inc. email formats with LeadIQ.

How much funding has Phil, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Phil, Inc. has raised $60M in funding. The last funding round occurred on Jul 08, 2025 for $60M.

When was Phil, Inc. founded?

Minus sign iconPlus sign icon
Phil, Inc. was founded in 2015.

Phil, Inc.

Pharmaceutical ManufacturingCalifornia, United States201-500 Employees

PHIL helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology and dedicated support. 

Streamline your medication access journey with the PhilRx Digital Hub. Our platform integrates with a national dispense network to deliver a seamless access experience that provides brand teams with full visibility into the drug channel.

Improve patient access and adherence, boost provider engagement, maximize covered dispenses, and drive gross-to-net with PHIL. Discover how we can help your brands reach their commercial potential at www.phil.us.

Section iconCompany Overview

Phone number
Website
phil.us
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $60M

    Phil, Inc. has raised a total of $60M of funding over 10 rounds. Their latest funding round was raised on Jul 08, 2025 in the amount of $60M.

  • $250M$500M

    Phil, Inc.'s revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $60M

    Phil, Inc. has raised a total of $60M of funding over 10 rounds. Their latest funding round was raised on Jul 08, 2025 in the amount of $60M.

  • $250M$500M

    Phil, Inc.'s revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.